Teicoplanin Dosing in Patients with Impaired Renal Function

Introduction to Teicoplanin Dosing

• The standard loading dose of teicoplanin for patients with impaired renal function is 6-12 mg/kg three times, followed by maintenance doses adjusted according to glomerular filtration rate (GFR) 1, 2, 3

Dosing Algorithm Based on Renal Function

• For patients with impaired renal function, the initial loading dose remains the same regardless of renal function: 6 mg/kg three times (or 12 mg/kg three times for severe infections) 1, 3
• Loading doses are critical to rapidly achieve therapeutic levels and are not affected by alterations in renal function 4

Maintenance Dose and Interval Based on GFR

• For GFR >90 mL/min, the maintenance dose is 6-12 mg/kg every 24 hours 1, 2
• For GFR 50-90 mL/min, the maintenance dose is 6-12 mg/kg every 24 hours 1, 2
• For GFR 10-50 mL/min, the maintenance dose is 6-12 mg/kg every 48 hours 1, 3
• For GFR <10 mL/min, the maintenance dose is 6-12 mg/kg every 72 hours 1, 5

Special Populations

• For hemodialysis patients, the loading dose is 12 mg/kg, followed by 6 mg/kg on days 2 and 3, and maintenance of 6 mg/kg once weekly 1, 3
• For CAPD peritonitis, intravenous dosing follows the same guidelines as for GFR <10 mL/min, and intraperitoneal dosing is 20 mg/L in each bag for the first week, 20 mg/kg every other bag for the second week, and 20 mg/kg in the night bag only for the third week 1, 3
• For CAVH(D)-CVVH(D), follow dosing recommendations for GFR 10-50 mL/min 1

Therapeutic Drug Monitoring

• Routine monitoring of teicoplanin levels is not generally recommended, but is indicated in specific situations such as S. aureus endocarditis or septic arthritis, major burns, intravenous drug users, patients with rapidly changing renal function, and immunocompromised patients 1, 2, 3

Higher Dosing Considerations

• For severe infections like endocarditis or septic arthritis, higher doses (12 mg/kg) are recommended to achieve trough concentrations of at least 20 mg/L 1
• In patients with normal renal function but increased volume of distribution, loading doses are particularly important to rapidly achieve therapeutic levels 4, 6

Common Pitfalls to Avoid

• Failure to provide adequate loading doses can lead to inadequate therapeutic levels, regardless of renal function 4
• Not extending dosing intervals appropriately in renal impairment can lead to drug accumulation 1
• Overlooking the need for therapeutic drug monitoring in high-risk situations or specific infections can lead to suboptimal outcomes 1, 3

Target Trough Concentrations

• For standard infections, the target trough concentration is ≥10 mg/L 1
• For severe infections such as endocarditis or septic arthritis, the target trough concentration is ≥20 mg/L 1

Teicoplanin Dosing in Patients with Impaired Renal Function

Introduction to Teicoplanin Dosing

• The Surviving Sepsis Campaign guidelines emphasize that teicoplanin requires loading doses in critically ill patients due to expanded extracellular volume from resuscitation, with a low volume of distribution 7, 8
• The European Society of Cardiology guidelines note that teicoplanin requires loading doses of 6 mg/kg every 12 hours for 3 days due to high protein binding (≥98%) and slow penetration into vegetations 9, 10

Loading Dose Strategy

• The loading dose is NOT affected by renal impairment and must be given at full dose to rapidly achieve therapeutic levels, as supported by Critical Care Medicine 7, 8
• The rationale is that loading doses depend on volume of distribution, not clearance, and critically ill patients often have expanded extracellular volume from fluid resuscitation that requires aggressive loading to achieve therapeutic levels quickly 7, 8

Maintenance Dosing and Special Considerations

• Recent pharmacokinetic studies in septic patients demonstrate that maintenance doses should be adjusted by renal function, with enhanced loading regimens necessary to achieve therapeutic levels 7, 8
• Achieving initial trough concentrations ≥15 μg/mL significantly improves clinical success rates in patients with renal dysfunction, as evidenced by research (75.0% vs 50.0%, p=0.008), although the specific citation for this statistic is not provided, the importance of achieving therapeutic levels is emphasized by Critical Care Medicine 7, 8

Teicoplanin Dosing Guidelines

Introduction to Teicoplanin Dosing

• The European Society of Cardiology recommends a loading dose of 6-12 mg/kg every 12 hours for three doses for standard infections, and 12 mg/kg every 12 hours for three doses for severe infections, such as endocarditis, septic arthritis, and bacteremia 11
• The Intensive Care Medicine society suggests that the loading dose is not affected by renal impairment and must be given at full dose, as it depends on volume of distribution, not clearance 12

Loading Dose Strategy

• The loading dose should be administered at full dose, regardless of renal status, to rapidly achieve therapeutic levels, with a recommended dose of 6-12 mg/kg every 12 hours for three doses 11
• In critically ill patients with expanded extracellular volume from fluid resuscitation, the loading strategy becomes even more critical to rapidly achieve therapeutic levels 12

Maintenance Dosing Based on Renal Function

• The maintenance dose should be adjusted according to GFR, with a dose of 6-12 mg/kg every 24 hours for GFR >50 mL/min, every 48 hours for GFR 10-50 mL/min, and every 72 hours for GFR <10 mL/min 12

Target Trough Concentrations and Monitoring

• The European Heart Journal recommends target trough concentrations of ≥10 mg/L for standard infections and ≥20 mg/L for severe infections, such as endocarditis, septic arthritis, and bacteremia 11
• Routine monitoring is not required for most patients, but is mandatory in situations such as S. aureus endocarditis or septic arthritis, major burns, intravenous drug users, rapidly changing renal function, and immunocompromised patients 11

Special Considerations for Renal Impairment

• Patients with renal impairment often have factors that increase teicoplanin requirements despite reduced clearance, such as fluid overload, hypoalbuminemia, and critical illness with expanded extracellular volume 12
• The therapeutic window is 15-30 mg/L for most infections, with levels >60 mg/L considered potentially toxic, and studies show that 600 mg daily dosing achieves therapeutic levels more frequently without increasing toxic levels 11